Mark Wickham

Principal, Phillips Ormonde Fitzpatrick

Mark is a Principal and leader of the Chemistry and Life Sciences team. His work focuses on the preparation and prosecution of patent applications in Australia and internationally, due diligence, freedom to operate and invalidity advice for the pharmaceutical, biotechnology, health and medical device industries, and has significant experience in opposition proceedings. Mark also sits on the Commercialisation Committee of the Australian Stroke Alliance, which is committed to address major gaps in health outcomes for Australians in rural, remote and Indigenous communities. Prior to joining Phillips Ormonde Fitzpatrick, Mark worked on the host response to infection, and published over 30 peer reviewed research articles that have been cited over 5500 times.